Kronos Bio, Inc. (KRON)
Kronos Bio, Inc. is a clinical development biopharmaceutical company. It engages in the business of developing therapeutics that target dysregulated transcription that causes cancer and other serious diseases. The company was founded by Arie S. Belldegrun, Joshua A. Kazam, David M. Tanen, and Christopher Wilfong on June 2, 2017 and is headquartered in San Mateo, CA.
Address
1300 S. EL CAMINO REAL
SAN MATEO, CA 94402
Founded
2017
Number of Employees
63
Website
http://www.kronosbio.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)